Hitting that 200 mark might drive interest up, but the real question is what people will actually do to get there. Sales could definitely spike once word spreads.
always wondered about that free peptide testing site that focused on glp1. they made you list your supplier before sending a kit. feels like either the fda or big pharma running a tracker to figure out who to target next.